Spiramycin Disarms <i>Pseudomonas aeruginosa</i> without Inhibiting Growth

• Egile Nagusiak: Matteo Calcagnile (Egilea), Inès Jeguirim (Egilea), Salvatore Maurizio Tredici (Egilea), Fabrizio Damiano (Egilea), Pietro Alifano (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-03-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Spiramycin is a 16-membered macrolide antibiotic currently used in therapy to treat infections caused by Gram-positive bacteria responsible for respiratory tract infections, and it is also effective against some Gram-negative bacteria and against <i>Toxoplasma</i> spp. In contrast, <i...